Aspirin interruption before neurosurgical interventions:A controversial problem

作     者：Alexander Kulikov Anton Konovalov Pier Paolo Pugnaloni Federico Bilotta 

作者机构：Department of AnesthesiologyBurdenko National Medical Research Center of NeurosurgeryMoscow 125047Russia Department of Vascular NeurosurgeryBurdenko National Medical Research Center of NeurosurgeryMoscow 125047Russia Department of AnesthesiologyCritical Care and Pain MedicineUniversity of Rome“Sapienza”Rome 00161Italy 

出 版 物：《World Journal of Cardiology》 (世界心脏病学杂志（英文版）（电子版）)

年 卷 期：2024年第16卷第4期

页      面：191-198页

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

主　　题：Aspirin Neurosurgery Postoperative complications Bleeding risk Brain tumor surgery Cerebrovascular surgery Spinal surgery 

摘      要：Aspirin is widely used for primary or secondary prevention of ischemic *** the same time,chronic aspirin consumption can affect blood clot formation during surgical intervention and increase intraoperative blood *** is especially important for high-risk surgery,including *** European Society of Cardiology guidelines recommend aspirin interruption for at least 7 d before neurosurgical intervention,but this suggestion is not supported by clinical *** narrative review presents evidence that challenges the necessity for aspirin interruption in neurosurgical patients,describes options for aspirin effect monitoring and the clinical implication of these methods,and summarizes current clinical data on bleeding risk associated with chronic aspirin therapy in neurosurgical patients,including brain tumor surgery,cerebrovascular procedures,and spinal surgery.